Last reviewed · How we verify
intrafen
intrafen is a Small molecule drug developed by Erzincan University. It is currently in Phase 1 development. Also known as: ibuprofen i.v..
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | intrafen |
|---|---|
| Also known as | ibuprofen i.v. |
| Sponsor | Erzincan University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Ultrasound-Guided Regional Blocks for Postoperative Analgesia After Laparoscopic Cholecystectomy (NA)
- Pain and Trismus Control in Third Molar Surgery: Ibuprofen, Ketamine, and Their Combination (NA)
- Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection (PHASE4)
- Paracetamol, Dexketoprofen and Ibuprofen In Non-Traumatic Acute Low Back Pain (PHASE4)
- Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache (PHASE4)
- Comparison of the Effectiveness of Preemptive Paracetamol and Ibuprofen in Acute Postoperative Pain (PHASE4)
- Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea (NA)
- Comparisons of iv Ibuprofen and iv Paracetamol During Bariatric Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intrafen CI brief — competitive landscape report
- intrafen updates RSS · CI watch RSS
- Erzincan University portfolio CI
Frequently asked questions about intrafen
What is intrafen?
Who makes intrafen?
Is intrafen also known as anything else?
What development phase is intrafen in?
Related
- Manufacturer: Erzincan University — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: ibuprofen i.v.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing